Trials / Sponsors / Transcend Therapeutics
Transcend Therapeutics
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1) Post Traumatic Stress Disorder | Phase 3 | 2026-03-01 |
| Completed | An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD Post Traumatic Stress Disorder | Phase 2 | 2024-04-04 |
| Completed | A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects Post Traumatic Stress Disorder | Phase 1 | 2024-03-20 |
| Completed | An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD Post Traumatic Stress Disorder | Phase 2 | 2024-03-06 |
| Completed | A Study to Assess the Use of Methylone in the Treatment of PTSD Post Traumatic Stress Disorder | Phase 1 / Phase 2 | 2023-03-01 |